Technology Transfer is the sharing of knowledge and facilities among different entities such as Federal laboratories, industry, universities, Federal, state and local governments and third party intermediaries. Federal technology transfer programs aim to make federally generated scientific and technological development accessible to private industry and state and local government. These recipients are encouraged to develop the technology further into new products, processes. Materials or services that will improve the quality of life and enhance industrial competitiveness. The instruments for this transfer of technology are through transactional agreements, such as material transfer agreements, confidential disclosure agreements, licenses and corporative research and development agreements.
Intellectual Property can be defined as “Creations of the
mind” - creative works or ideas embodied in a form that can be shared or can
enable others to recreate, emulate, or manufacture them. There are four ways to
protect intellectual property - patents, trademarks, copyrights or trade secrets.
Under the terms of the Operations and Technical Support (OTS) contract between NCI
and Leidos Biomedical Research, Inc. (formerly SAIC-Frederick), all intellectual property developed by
their employees is assigned to the Federal Government (N1-CO-12400.B.2(x)
and FAR 52.227-13-(deviated)).
In practice, this means that all intellectual property developed by Leidos
employees will be owned by the Federal Government.
Inventions and patents - any way of doing or making things, machine,
manufacture, design, or composition of matter, or any new and useful improvement
thereof, or any variety of plant, which is or may be patentable. All new inventions
made at the Frederick National Lab must be reported to the Federal Government. This reporting
is in the form of an Employee
Invention Report (EIR). The EIR must be complete and signed and witnessed.
The Leidos cover
sheet must also be completed before submitting it along with the EIR to
NCI TTB and Leidos IP Administrator. NCI will make the final decision on
which inventions to seek patent protection for.
Helpful NIH-NCI Links for Inventions, Partnering and Intellectual Property
NCI Technology Transfer Branch
NIH Office of Technology Transfer
NIH Technology Transfer Training
NCI CCR Office
of Science and Technology Partnerships
NCI Office of Technology
and Industrial Relations
Frequently asked Questions (FAQs) - Under Construction. If you
would like to request that information be added to the FAQ, please submit your suggestion
to the Intellectual Property Administrator
using the contact information below.
For more information contact:
Intellectual Property Administrator (Contractor)
National Cancer Institute at Frederick
PO Box B
1050 Boyles Street
Frederick, MD 21702-1201